BeOne Medicines (ONC) Raw Materials (2024 - 2026)

BeOne Medicines (ONC) has reported Raw Materials for 3 consecutive years, with $274.2 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Raw Materials changed N/A year-over-year to $274.2 million; the TTM figure through Mar 2026 stood at $274.2 million (changed N/A YoY), while the FY2025 annual figure was $236.2 million, up 38.46% from the prior year.
• Raw Materials advanced to $274.2 million in Q1 2026 per ONC's latest filing, from $236.2 million in the prior quarter.
• Across five years, Raw Materials topped out at $274.2 million in Q1 2026 and bottomed at $170.6 million in Q4 2024.
• Historically, Raw Materials has averaged $227.0 million across 3 years, with a median of $236.2 million in 2025.
• On a YoY basis, Raw Materials climbed as much as 38.46% in 2025 and fell as far as 38.46% in 2025.
• BeOne Medicines' Raw Materials stood at $170.6 million in 2024, then jumped by 38.46% to $236.2 million in 2025, then rose by 16.1% to $274.2 million in 2026.
• Business Quant data shows ONC's Raw Materials at $274.2 million in Q1 2026, $236.2 million in Q4 2025, and $170.6 million in Q4 2024.